RE:RE:RE:RE:Ronco et al Aug 2022 seems to still be pro-PMX (golden hr) Hmmmm
Disingenuous to imply the next 40 will be enrolled at the rate of one patient per month (or even two) - given the possiblity of 20 + sites, RSV & Covid waning etc. I'm willing to see what happens Q1 and Q2
Didn't say stoppage at 90 was a given. Only VERY possible IMO.
Management HAS let Shareholders down (there I said it ...happy ?....actually I have said it many, many times, but you were not listening)
Didn't say investors should invest more...only said that buying more was one of the few ways to protect onself from nasty effects of dilution. I use the strategy a fair bit, not just for Spectral. Often works out very well.
Loss of control of Dialco (really 20% distirbution rights for US) does not equate to a loss of the asset or a potential for a large payback (in various forms, including a reduced need to bring it to the next level, relative to their partner Infomed, or perhaps enhanced rights - ie.g. no finite end to DA)
MM